http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd
Influenza Antiviral Drugs and Patent Law Issues
Identifies and analyzes aspects of patent law affecting the availability and affordability of avian influenza antiviral medications such as the vaccine Tamiflu, produced by Roche, Inc. Examines legal options for increasing Tamiflu drug production, including the use of compulsory licensing under the Agreement on Trade-Related Aspects of Intellectual Property Rights and U.S. Code, and through sublicensing agreements voluntarily negotiated by Roche, Inc., with third-parties of its choosing.
Record is based on bibliographic data in ProQuest U.S. Congressional Research Digital Collection (last viewed Dec. 2010). Reuse except for individual research requires license from ProQuest, LLC.
Library of Congress. Congressional Research Service.